Drug Type TF Decoy |
Synonyms E2F decoy ODN, E2F duplex decoy, E2F transcription factor decoy + [7] |
Target |
Action inhibitors |
Mechanism E2F1 inhibitors(Transcription factor E2F1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |



| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Coronary Artery Disease | Phase 3 | United States | 01 Jul 2002 | |
| Arterial Occlusive Diseases | Phase 3 | Canada | 01 Nov 2001 | |
| Graft Occlusion, Vascular | Phase 3 | United States | 01 Nov 2001 | |
| Graft Occlusion, Vascular | Phase 3 | Canada | 01 Nov 2001 | |
| Hyperplasia | Phase 3 | United States | 01 Nov 2001 | |
| Hyperplasia | Phase 3 | Canada | 01 Nov 2001 | |
| Ischemia | Phase 3 | United States | 01 Nov 2001 | |
| Ischemia | Phase 3 | Canada | 01 Nov 2001 | |
| Peripheral Vascular Diseases | Phase 3 | United States | 01 Nov 2001 | |
| Peripheral Vascular Diseases | Phase 3 | Canada | 01 Nov 2001 |
Phase 3 | - | - | jkvokqrxem(hrhwpuznok) = kdwuffkkqx wzvvqoxlld (tjhntvagey ) View more | - | 01 Sep 2012 | ||
Placebo | jkvokqrxem(hrhwpuznok) = zdcuuianpk wzvvqoxlld (tjhntvagey ) View more | ||||||
Phase 3 | 3,014 | vhjinvfwya(mnjombnhfb) = pqtctwgcsr zxakplvtib (glokyclhwf ) View more | Negative | 16 Nov 2005 | |||
Placebo | vhjinvfwya(mnjombnhfb) = lozsukqizc zxakplvtib (glokyclhwf ) View more |





